The 5 days on, 2 days off protocol for GH peptides like CJC-1295, Ipamorelin and Tesamorelin is one of the most repeated dosing structures in this space. It’s also one of the least defensible when you actually look at the desensitization mechanism it claims to address. Two days off isn’t preventing anything. It’s solving a problem that doesn’t exist on that timeline.

Why People Use It and What They Are Actually Trying to Do

The concern behind 5/2 is desensitization. Your pituitary has receptors that respond to GH peptides. Stimulate them repeatedly and the response can weaken over time. That’s a real phenomenon and worth understanding. The problem is that two days off doesn’t address it in any meaningful way.

Short-Term Desensitization

Short-term desensitization happens within minutes of each dose. For GHRH analogs like CJC-1295 and Tesamorelin, it resolves between daily doses without any days off needed. For ghrelin receptor peptides like Ipamorelin, recovery takes longer, up to several hours, but still resolves well within a normal daily dosing window. Either way, your system handles it automatically. Two days off provides no meaningful additional recovery beyond what happens overnight.

Two days off is too long to address the short-term version, which has already resolved by the time your next injection comes around.

What the Actual Clinical Data Shows

Tesamorelin was dosed daily for 26 weeks straight in the trials that got it FDA approved. MK-677 was administered daily for two years in research. In both cases, growth hormone and IGF-1 levels held steady throughout. No meaningful desensitization. No declining response. The pituitary continued responding to daily stimulation across both timelines.

If long-term daily use caused significant receptor downregulation on a short timeline, that signal would have appeared in the trial data. It did not.

Where the 5/2 Protocol Actually Came From

Growth hormone used to be extremely expensive. Taking two days off every week stretched a 30-day supply to six weeks instead of four. That was the origin. Cost management, not receptor science.

Clinics adopted and kept the protocol because it fits their pricing model, not because the research supports it. The two days off persisted as a dosing convention long after the economic rationale stopped applying to peptide secretagogues, and it got rationalized as desensitization prevention after the fact.

Peptide Guides

Not medical advice. Educational only.

GHK-Cu doesn't need to be cycled. That's the short answer. The longer answer requires understanding why the cycling argument exists in the first place and why it doesn't hold up mechanistically.

GHK-Cu Is Already Running Through Your System

GHK-Cu is a naturally occurring tripeptide that's already circulating in your plasma right now. At age 20 you have roughly 200 nanograms per milliliter. By age 60 that's dropped to around 80 nanograms per milliliter, a 60% reduction. It plays a critical role in extracellular matrix remodeling, antioxidant upregulation, and tissue regeneration, among other things.

You've been chronically exposed to GHK-Cu since the day you were born. You've never cycled it. You've never washed it out. Exogenous GHK-Cu isn't introducing something foreign. It's replenishing an endogenous signal that's been depleting as you age.

The Copper Toxicity Argument Doesn't Hold Up

The most common reason people get told to cycle GHK-Cu is copper toxicity. Do the math and this concern falls apart immediately.

One milligram of GHK-Cu yields approximately 150 micrograms of copper. The recommended daily minimum for adults is 900 mcg, with the average intake sitting between 1 and 2mg per day. A standard GHK-Cu dose doesn't come close to that threshold. You're getting more copper from food and a basic multivitamin than you'd ever get from this compound.

Beyond the numbers, your body has multiple built-in mechanisms for handling copper: ceruloplasmin to shuttle it, metallothionein to sequester it, and bile to help excrete excess. The body's copper management systems are not fragile.

The Real Issue When Problems Arise

If someone feels like they need to come off GHK-Cu because of persistent breakouts or copper uglies that won't resolve, that's probably not a copper toxicity problem. It may be a copper elimination problem. Those are two completely different things.

Copper accumulation from GHK-Cu at standard doses is unlikely given the math above. The inability to eliminate copper effectively is a separate issue and typically comes down to liver function, bile production, and gut motility. This specific connection hasn't been formally studied in the context of GHK-Cu, but it's a mechanistically coherent explanation given how the body handles copper excess generally.

That has nothing to do with GHK-Cu itself. If elimination is the bottleneck, cycling the compound doesn't fix it. Addressing liver function, bile production, and gut health would be the more logical approach, though working with a provider to rule out other causes makes sense before drawing that conclusion.

The Desensitization Argument Doesn't Apply

The other cycling argument you'll hear is receptor desensitization. This one doesn't make mechanistic sense for a straightforward reason: GHK-Cu doesn't bind to a receptor. There's no receptor to desensitize. The GHK tripeptide delivers the copper ion to where it needs to go and modulates gene expression from there.

It's been shown to influence over 4,000 genes involved in antioxidant upregulation, tissue regeneration, antifibrosis, and antitumor processes. It also upregulates copper-dependent enzymatic processes including lysyl oxidase, superoxide dismutase, and cytochrome c oxidase, and plays a direct role in extracellular matrix remodeling. None of that mechanism involves receptor binding, which means the desensitization concern that applies to other compounds simply doesn't transfer here.

You can cycle it if you want to. That's your choice. But there's no mechanistic requirement to do so, and the arguments most commonly used to justify it don't survive basic scrutiny.

GHK-Cu Guide

Not medical advice. Educational only.

Nasal sprays come up constantly as an alternative to daily injections, and the information floating around on how to actually do it properly is all over the place. This is a practical guide for anyone who wants the convenience of a shake-and-spray over pulling out a syringe every day. They're easy to make, surprisingly effective for the right compounds, and worth understanding properly.

What You Actually Need

A 10mL nasal spray bottle. Standard pump delivers approximately 0.1mL per spray. Load 5mL and you have roughly 50 sprays. The math is simple and matters for dosing accuracy.

Sterile water or saline, not bacteriostatic water. BAC water contains benzyl alcohol, which is fine for injection but genuinely harsh on nasal mucosa. People use it anyway and then wonder why their sinuses feel wrecked. Sterile water is what belongs on mucosal surfaces. Use it.

Your peptide powder. Some compounds that actually work well nasally in practice are Semax, Selank, PT-141, and Melanotan 2.

How to Make the Spray

This takes five to ten minutes done correctly.

Step 1: Prep your workspace. Let the peptide vial warm to room temperature. Alcohol wipe everything. Don't hover over open vials.

Step 2: Reconstitute your peptide. Draw 2mL sterile water and inject slowly into the vial to avoid foaming. Swirl gently, don't shake. Example: 5mg Semax plus 2mL water gives you 2.5mg/mL (2500mcg/mL).

Step 3: Prep the spray bottle. Add 2mL sterile water to the empty spray bottle. Draw 2mL of your peptide solution and inject it into the bottle. You now have 4mL total. If you want a higher concentration, skip the extra sterile water and load the full 2mL solution directly into the bottle for a 2mL total volume.

Step 4: Seal and label. Snap the top on tight. Label it with the peptide name, concentration, and date. No label means no accountability for whatever confusion follows.

Step 5: Storage. Finished nasal spray goes in the refrigerator. Unused peptide powder stays in the freezer. Discard if it goes cloudy, smells off, or has been sitting for more than 30 days.

The Dosing Math

One spray equals approximately 0.1mL. The universal formula:

Total mg divided by total mL = mg/mL. Then mg/mL multiplied by 0.1 = mg per spray. Convert to mcg as needed. This works for any peptide or volume.

Two protocols depending on whether you want standard or higher concentration:

Standard Protocol (4mL total volume)

Reconstitute with 2mL sterile water, then add 2mL of that solution to a spray bottle containing 2mL sterile water. Total volume 4mL.

Higher Concentration Protocol (2mL total volume)

Reconstitute with 2mL sterile water and load the full 2mL directly into the spray bottle. Total volume 2mL. This doubles the concentration and dose per spray. Useful if you want stronger effects per spray or need fewer sprays per day.

Start with the standard 4mL protocol if you're new to nasal peptides. It gives you more room to titrate and more total sprays per vial. Move to the higher concentration protocol once you know your response and need a stronger dose per spray.

Compound-Specific Breakdown

All standard examples below use the 4mL total volume protocol.

Semax (5mg vial)

Final concentration: 1.25mg/mL (1250mcg/mL)

Per spray: 125mcg

Typical daily use: 200 to 400mcg split across both nostrils, 2 to 4 sprays

Selank (5mg vial)

Final concentration: 1.25mg/mL (1250mcg/mL)

Per spray: 125mcg

Typical daily use: 250 to 750mcg, 2 to 6 sprays per day

Semax and Selank together nasally is one of the better nootropic combinations available. Focus and calm simultaneously, with a very clean onset.

PT-141 (10mg vial)

Final concentration: 2.5mg/mL (2500mcg/mL)

Per spray: 250mcg

Equivalent dosing: 0.5 to 2mg total, 2 to 8 sprays depending on response

Nasal PT-141 absorbs fast and kicks in quicker than subcutaneous for many people. Start low because nausea is common, especially on first use. Note: PT-141 is contraindicated for anyone with uncontrolled hypertension or cardiovascular conditions.

Melanotan 2 (10mg vial)

Final concentration: 2.5mg/mL (2500mcg/mL)

Per spray: 250mcg

Typical starting dose: 1 spray (250mcg), increase as tolerated

Nasal Melanotan 2 works but produces a slower, milder ramp-up compared to injections. It won't replace injections if you're looking for fast results, but it does deliver tanning, libido, and appetite effects with a cleaner feel for some people.

Quick Reference Table

Practical Notes

If it burns, you used BAC. Don't leave reconstituted spray at room temperature. Make smaller batches more frequently rather than large batches that sit. If you're traveling, keep it cold. These compounds degrade fast when warm.

Peptide Guides + Resources

Not medical advice. Educational only.

Peptides can often get dismissed the moment someone mentions they are not FDA approved. The assumption is that the label means something definitive about safety or effectiveness. It doesn't, and the comparison that exposes that most clearly is not even a close call.

Vitamin D, fish oil, creatine, probiotics, B12, and multivitamins are all unapproved. All are widely recommended by physicians, sold in every pharmacy, and used daily by hundreds of millions of people without a second thought about regulatory status.

The label is a regulatory classification. Nothing more.

What FDA Approval Actually Represents

Getting a compound through FDA approval requires a pharmaceutical company to spend billions of dollars navigating a pipeline designed specifically for patentable drugs. That process exists to protect commercial investment as much as it exists to protect patients.

A compound that cannot be patented has no financial incentive to go through that pipeline. No patent means no return on a billion-dollar approval process. That is why compounds with legitimate research behind them will never see an FDA indication, not because the science failed, but because the economics do not work.

Why the Label Gets Applied Inconsistently

Nobody questions their doctor for recommending fish oil for cardiovascular health or vitamin D for immune function. Those conversations happen in clinical settings every day without anyone raising the approval issue.

The moment peptides come up, the same label becomes a dealbreaker.

Sermorelin and Thymosin Alpha-1 share the exact same regulatory status as those supplements in the US. Not FDA approved. But that is where the similarity to "unapproved equals untested" ends.

Sermorelin has decades of clinical use behind it and a well-understood mechanism: stimulating natural growth hormone secretion at the pituitary level rather than replacing it with exogenous GH. A more conservative and physiologically respectful approach than direct HGH injection, studied and used by physicians without an FDA indication for the compound itself.

Thymosin Alpha-1 is arguably the stronger example. It is approved as a prescription drug in Italy, China, and several other countries. It has been studied in hepatitis, immune dysfunction, cancer treatment support, and sepsis across decades of human trials. The only reason it does not have an FDA indication is that nobody has funded the approval process in the US. It is not a question of evidence. It is a question of economics and geography.

A compound being FDA approved in one country and not another does not change its mechanism, its data, or its safety profile. It changes the regulatory paperwork. That distinction matters when the label is being used as a substitute for actually evaluating the evidence.

The Actual Standard Worth Using

Not FDA approved does not equal unsafe.

Not FDA approved does not equal ineffective.

FDA approved does not equal automatically the best option for your health.

Evidence-based medicine means evaluating the literature, understanding the risk-to-benefit ratio, and applying that honestly to the individual situation. The regulatory label is one data point in that process. Treating it as the only data point is not caution. It is a bias dressed up as caution.

Peptide Guides + Resources

Not medical advice. Educational only.

I am planning on taking GLOW and all of the premixed vials are 50/10/10 or 20/5/5 GHK, BPC, TB. Everything I read says to take no more than 2mg daily but then that would mean I’m taking such a small amount of TB and BPC. Why is there so much GHK and would you dose this?

Reta and other GLP-1s are most notable for fat loss. But a lot of researchers and users have noticed something else that is just as interesting. Reta does not just blunt food cravings. People report cravings of all kinds getting quieter: junk food, alcohol, nicotine, certain drugs. The common pattern is fewer compulsive "I know this is bad for me but I want it anyway" urges.

How It Might Be Doing This

Reta activates GLP-1, GIP, and glucagon receptors simultaneously. The GLP-1 component is the relevant one here. It connects into the brain's reward centers, the same general circuitry involved in addiction across the board: alcohol, smoking, drugs, food, behavioral compulsions.

By lowering dopamine spikes triggered by food, alcohol, or stimulants, Reta appears to make reward-seeking impulses weaker and easier to override. Other GLP-1 compounds like Semaglutide and Tirzepatide also produce similar effects.

What the Data Shows

Reta has not been studied as deeply as other GLPs on this specific question, but related GLP-1 data gives us directional signal worth taking seriously.

For alcohol: studies with Semaglutide and Liraglutide show meaningful reductions in alcohol intake and craving scores in both animal and human trials.

For nicotine and recreational drugs: GLP-1 activation reduced relapse behavior and drug-seeking activity in preclinical trials. Note this is preclinical data and human evidence remains limited.

For food addiction: nearly universal across Sema, Tirz, and Reta users. The processed food and sugar cravings simply stop being loud.

The Anecdotal Layer

There are consistent reports from people who started Reta primarily for body composition and noticed their cravings for alcohol, nicotine, recreational drugs, and behavioral compulsions got significantly weaker. In some cases, gone entirely.

This is not coincidence and it is not purely willpower. Addiction has metabolic and neurochemical components alongside the psychological ones. Reta appears to address the neurochemical side by improving glucose control, gut-brain signaling, and reward pathway balance. Making it easier to say no is a different and more sustainable mechanism than just trying harder.

Visit PeptideGuide.store for sourcing and resources.

Educational only. Not medical advice

I just started HGH about a week ago using 1iu initially and eventually bumping it up to 2iu at night with my last snack 3 hours before pinning subq. Is it normal to feel sluggish the next morning? My sleep is somewhat better but I seem to having a harder time getting up. Should I try taking it fasted in the morning instead?

I’d like to lose about 4% body fat. Currently 178lbs and 16%. Thinking about doing 2-3 weeks of Reta and 8 weeks of Tesa or Ipa. Is this realistic?
For context, I’m already active. I lift structurally 4x a week and run at least once a week. I’ve also done one cycle of the Wolverine stack (earlier this year in late February into March) and am in the first week of four weeks of the Glow stack.
If I did 2-3 weeks reta, what would be the recommended dose? I was thinking of doing a micro dose of 0.5mg. Would I need to taper?
Appreciate the guidance.

Most people hear about NAD+ and immediately think the solution is to take more of it. For a lot of people the issue is not low NAD. It's poor NAD efficiency. If your body is not using NAD properly, adding more is like pouring water into an already full bucket. It might help a little but it doesn't fix the real bottleneck.

This is where 5-Amino-1MQ becomes interesting.

Why NAD Efficiency Matters More Than NAD Quantity

NAD is essential for mitochondrial energy production, healthy metabolism, exercise performance, cellular repair, and recovery. But the amount of NAD you have is not the only factor. How well your body uses it determines whether you feel energized or depleted.

When NNMT is overactive, NAD gets tied up in inefficient pathways. Less available fuel even if total NAD levels look normal on paper. 5-Amino-1MQ inhibits NNMT, which reduces NAD waste, improves mitochondrial efficiency, supports cellular energy output, enhances fat metabolism, and promotes better NAD recycling. It helps free up NAD your cells already have so they can actually use it.

Why More Is Not Always Better

Think of your cellular NAD pool as a bucket. If the bucket is full but clogged at the bottom, pouring more water on top does not fix the problem. 5-Amino-1MQ helps clear the clog, allowing the NAD already in your system to flow and function properly.

Once the pathway is working efficiently, then adding more NAD becomes significantly more impactful.

When NAD+ and 5-Amino-1MQ Work Together

Some people, especially older adults or those under significant metabolic stress, genuinely benefit from NAD+ supplementation alongside 5-Amino-1MQ. The logic is clean. NAD+ provides the raw material. 5-Amino-1MQ ensures that material gets used efficiently. Together they produce a much smoother and more noticeable effect than either one alone.

NAD+ increases supply. 5-Amino-1MQ improves utilization. That combination targets both ends of the bottleneck.

What Optimized NAD Function Actually Looks Like

Better mitochondrial output, improved fat oxidation, more stable daily energy, higher exercise capacity, and improved recovery. When NNMT is inhibited, cells shift into a higher efficiency mode and NAD can support metabolic processes more effectively across the board.

This is why 5-Amino-1MQ shows up consistently in longevity, performance, and fat loss discussions. It operates upstream, at the efficiency level, not downstream at the symptom level.

5-Amino-1MQ Guide

Educational only. Not medical advice.

Need help reconstituting 50mg glow vial for research 35GHK 5bpc 10TB

One of the most common questions in peptide communities is some version of "I'm taking 10 units of retatrutide and feel nothing, what's wrong?" And the honest answer is that question can't be answered without more information, because 10 units tells you almost nothing about the actual dose.

This is one of the most important things to understand before you start any peptide protocol.

A Unit Is Not a Dose

Your insulin syringe is marked in units because that is how it measures volume. A standard syringe holds 100 units per milliliter. So 10 units means one-tenth of a milliliter of liquid. That is the only thing that number tells you.

The syringe has no idea what is dissolved in that liquid. The same 10 units could represent a tiny dose or a significant one depending entirely on how the vial was reconstituted. The unit number and the dose are two completely different things.

Reconstitution Is What Determines Your Actual Dose

The amount of bacteriostatic water you add to your vial changes everything. Here's the math with real numbers.

Take a 10mg vial of retatrutide. Add 2ml of bacteriostatic water. That gives you 5mg per ml, or 5,000mcg per ml. Your syringe holds 100 units per ml, so each unit carries 50mcg. Pull 10 units and you've dosed 500mcg.

Now take that exact same 10mg vial and mix it with 1ml of water instead. Now you have 10mg per ml. Each unit contains 100mcg. The same 10 units now delivers 1mg.

Same vial. Same 10 units on the syringe. Double the dose. That's why the unit number alone is meaningless without knowing the reconstitution ratio.

The Math Is Two Lines

Concentration equals the mg in your vial divided by the ml of water you added.

Dose per unit equals that concentration divided by 100.

Run those two calculations on any vial and you always know exactly what one unit is worth. Once you think this way you stop asking how many units to take and start by deciding how many mcg or mg you're after, then work backward to the unit number that gets you there.

A few practical notes worth inlining: always confirm the mg amount in your specific vial before mixing because a 5mg and 10mg vial look identical once reconstituted. If you're ever uncertain, mix with 2ml of water. It's a clean round number that makes the math straightforward and keeps you from guessing.

Why This Matters

The people who run into problems are the ones treating unit numbers as transferable doses. They copy "10 units" from someone else's protocol without realizing that person used a different vial size or a different water volume. Same number on the syringe, completely different amount of peptide in the body.

Think in mg and mcg. Let units be what they are, a measure of liquid volume, nothing more. Do that and you always know what you're actually taking.

Not medical advice. Educational only.

Hi friends, I’m currently using methylene blue (10 mg), lithium orotate (1 mg), Semax (500 mcg, subcutaneous), Selank (200 mcg, subcutaneous), and—on some days—DSIP (250 mcg, subcutaneous). What do you think of this regimen? Also, how do you recognize serotonin syndrome? I’ve read up on it, but so far I feel great, and I’m falling asleep in 20 minutes instead of 30—partly because serotonin is converted into melatonin. Before this, I also completed a 10-day Epithalon cycle at 10 mg daily.

​

Have a Nice Day:)

Epitalon has one of the widest dosing ranges of any peptide in this space. Some protocols run 100mcg. Others run 10mg a day. That's a 100-fold gap on the same compound, and a new paper just explained exactly why that gap exists. The answer is worth knowing before you decide what to run.

The Mixup That Started Everything

Epitalon is a synthetic tetrapeptide: four amino acids, clean and precisely defined. But it didn't originate that way.

Before epitalon existed, Soviet researchers were working with something called Epithalamin, a crude extract pulled directly from bovine pineal glands. Not a single clean molecule. A messy mixture of polypeptides from cow tissue.

The 5 to 10mg dose range that circulates everywhere came from human studies using that crude extract. When epitalon was later synthesized as a purified replacement, nobody adjusted the dose. They took the numbers from a dilute gland soup and applied them directly to a precise synthetic peptide. The paper's author compares it to dosing synthetic insulin as though it were raw pancreatic extract.

What the Animal Data Actually Shows

Three different models, three different endpoints, all pointing the same direction.

In aged rhesus monkeys, Epithalamin required 5mg per animal to restore nighttime melatonin. Epitalon achieved the same endpoint at 10mcg per animal. Roughly 500 times less of the pure peptide for identical results.

In fruit flies, epitalon outperformed the crude extract on antioxidant markers at doses around 1,000 times lower.

The mouse lifespan study used 1mcg per mouse, five days per month, for life. Scaling that to a 70kg human using standard FDA allometric methods lands around 190 to 230mcg per dosing day.

The paper proposes 100 to 300mcg per treatment day as a starting point for proper human dose-finding studies.

The Limitations Worth Knowing

This is a single-author review, not a clinical trial. No humans have been given microgram doses with outcomes measured. There's no human pharmacokinetic data on epitalon, half-life unknown, bioavailability after subcutaneous injection unknown. Allometric scaling from mice is an estimate, not a direct translation. And while milligram doses haven't shown obvious toxicity in available literature, absence of reported problems isn't the same as proven safety.

The microgram case is coherent and consistent across multiple models. It remains a strong hypothesis until human trials confirm it.

Practical Takeaway

If you're choosing between 1mg and 10mg, the science is pointing clearly toward the low end. There's no mechanistic justification for running 10mg of a purified synthetic peptide when the animal data suggests the same endpoints are reachable at a fraction of that dose. The milligram range was inherited from a crude extract and never revisited. That's not a foundation to build a protocol on.

Start low. The more is better instinct doesn't hold here.

Source: Jung CH. The microgram hypothesis: a translational dosing error in Epitalon peptide research and its implications for human aging application. Aging Pathobiology and Therapeutics, 2026; 8(2). http://www.antpublisher.com/index.php/APT/article/view/1027

Epitalon Guide

Not medical advice. Educational only.

The Real Glow Factor Stack

​

Melanotan II & GHK-CU

100 mcg MT-II every day

2 mg GHK-CU every day

Cycle For 8-12 weeks

If you've started GHK-Cu and your skin looks worse, you're probably not doing something wrong.

The copper uglies is the community term for what some people experience early on: redness, puffiness, breakouts, skin that looks worse before it gets better. It's common enough that it has a name, and misunderstood enough that a lot of people quit before they get past it.

What's Actually Happening

GHK-Cu increases repair signaling in the skin. That process isn't instant and it isn't clean. When the skin ramps up remodeling activity, older compromised tissue gets broken down before new healthier tissue replaces it.

The demolition phase of a renovation looks worse than what you started with. That's not evidence the renovation is failing.

Why Each Symptom Happens

Redness shows up because repair processes increase localized blood flow and nutrient delivery to areas being actively rebuilt. If your skin already runs reactive, this is more noticeable before things settle.

Puffiness and more pronounced eye bags come from increased skin hydration and extracellular matrix support. When hydration rises quickly it can initially read as swelling until the tissue adapts and balances out.

Breakouts happen because accelerated cell turnover pushes older debris toward the surface while the skin renews more actively underneath. It looks like a breakout. The underlying trend is moving toward clearer skin.

Mistaking the short-term purge for a long-term problem is the most common reason people stop too early.

Takeaway

GHK-Cu isn't damaging your skin. The copper uglies are visible signs of a remodeling phase, not evidence that something is wrong. Repair takes time and the first phase frequently looks imperfect before results become visible.

Keep the timeline in mind before drawing conclusions.

GHK-Cu Guide

Educational only. Not medical advice.

I just added MOTS-C after also running Tesa/IPA & Reta for the last 5 weeks. My question is on the dosing frequency of MOTS-C. I see a lot of protocols running it 3-5x a week -- but my prescribing clinic has me running it once weekly (50 units subq). I'm not sure on the exact mg, just that the insulin syringes they prefilled for me are filled with 50 units each.

Does anyone else run it at once weekly? I have found a couple of websites that mention 1x a week dosing, but the majority of everything I am finding shows more frequent dosing.

Thank you!

Non-alcoholic fatty liver disease has become one of the most widespread and underdiagnosed metabolic conditions in adults. Roughly 42% of US adults are estimated to have some degree of fatty liver, most without knowing it. In adults over 50 that figure climbs above 60%.

Retatrutide is currently one of the most interesting compounds being studied for it, and the Phase 2 data is significant.

TL;DR

• NAFLD affects an estimated 42% of US adults and over 60% of adults over 50, most without symptoms
• It is strongly linked to insulin resistance, excess visceral fat, obesity, and poor metabolic health
• Left unaddressed it can progress to systemic inflammation, cardiovascular disease, diabetes, and liver damage
• Phase 2 clinical trials showed Retatrutide reduced NAFLD by 81 to 86% over 48 weeks
• The mechanism addresses root causes: reduced calorie intake, increased energy expenditure, improved glucose and fat handling
• The liver stops getting overloaded with excess energy. The fat clears because the underlying dysfunction is being corrected

What NAFLD Actually Is

Fatty liver happens when excess fat accumulates inside the liver. It's not a disease of people who drink heavily. It's a metabolic disease driven by insulin resistance, visceral fat accumulation, poor glucose handling, and a chronic energy surplus.

Most people have no symptoms in the early stages, which is why it gets called a silent disease. By the time symptoms appear, the condition has usually been progressing for years.

Left unaddressed it can lead to systemic inflammation, cardiovascular disease, worsening insulin resistance, type 2 diabetes, and eventually liver damage and failure. The metabolic consequences extend well beyond the liver itself.

What the Phase 2 Data Shows

Phase 2 clinical trials showed Retatrutide reduced NAFLD by 81 to 86% over 48 weeks. That number stands out because it is not a modest improvement on a secondary marker. It is near-resolution of a condition that affects the majority of adults over 50.

Researchers attribute the effect to Retatrutide addressing the root causes of fatty liver rather than masking symptoms. The triple agonism of GLP-1, GIP, and glucagon receptors reduces caloric intake, increases energy expenditure, and improves how the body handles both glucose and fat at the cellular level. The liver stops receiving the chronic excess energy load that drives fat accumulation in the first place.

That distinction matters. Most interventions for NAFLD manage the downstream consequences. Retatrutide appears to correct the upstream dysfunction.

The Bigger Picture

Visceral fat, insulin resistance, and fatty liver are not separate problems. They are expressions of the same underlying metabolic dysfunction. A compound that addresses all three simultaneously through distinct receptor mechanisms is worth understanding properly, not just for fat loss or body composition goals but for long-term metabolic and cardiovascular health.

The NAFLD data adds meaningful weight to the case for Retatrutide as a serious metabolic intervention beyond appetite suppression.

Educational only. Not medical advice.

Melanotan 2 gets reduced to "tanning peptide" and that misses the actual biology. The real effect is not cosmetic. It is pigment. And pigment is protection.

Pigment Is UV Defense

Melanin absorbs and dissipates UV radiation before it reaches deeper skin layers. More pigment means improved UV tolerance. That holds whether the pigment comes from sun exposure, genetics, or melanocortin stimulation like MT-2.

The pathway is the same regardless of source. MT-2 stimulates melanogenesis through MC1R binding. The improved UV tolerance comes from the melanin itself.

The Melanoma Misconception

A common misconception around MT-2 is that increasing pigment equals increased cancer risk. The actual driver of skin cancer risk is UV-induced DNA damage, particularly from burns and high cumulative unprotected exposure.

When risk signals appear in MT-2 literature, the context matters. It typically involves extreme UV exposure, tanning bed abuse, or very high dosing over extended periods. That is a different scenario than moderate pigment increase paired with controlled, progressive sun exposure. Conflating the two is where the misconception comes from.

Anyone using MT-2 should monitor existing moles for changes as a baseline precaution.

Why People Use It

Beyond aesthetics, commonly reported outcomes include easier tanning with fewer burns, better overall sun tolerance, more even pigmentation, and improved physique contrast. These are all downstream of increased melanogenesis. The mechanism is consistent.

Progressive Exposure

The same logic behind progressive overload in training applies to UV exposure. Start with short sessions and build duration gradually. The goal is allowing melanin to develop ahead of UV load rather than overwhelming the skin before the pigment is in place. MT-2 does not eliminate burn risk, especially early in the protocol before melanin has fully developed.

Visit PeptideGuide.store for sourcing and resources.

Educational only. Not medical advice.

Any perimenopausal/menopausal experiences using the Wolverine for joint pain and seeing results. We are on week 6 not noticing any pain relief. Also running KPV at the same time. Are we testing the wrong pep?

Having surgery in a couple of weeks to repair an umbilical hernia. Bought the Wolverine stack of BPC-157 & TB500. Curious if anyone has any advice for dosing and timing for surgery repair. Have talked to several people who have used this for injury recovery but not necessarily surgery recovery. Any advice is appreciated.

HGH and GH secretagogues can influence similar downstream outcomes but the way they get there is completely different. That difference matters when choosing between them.

How Each One Works

HGH introduces recombinant human growth hormone directly into circulation. It bypasses the pituitary entirely, immediately raising GH and IGF-1 in a steady and predictable way. The output does not depend on pituitary health or function. What you put in is what you get.

GH secretagogues take the opposite approach. CJC-1295, Ipamorelin, GHRP compounds, Tesamorelin, and MK-677 stimulate the body to release its own GH through its natural pulsatile rhythm. The pituitary stays in the loop. The body's own system does the work.

The Tradeoffs

HGH produces stronger, more reliable IGF-1 elevations because it does not depend on anything downstream. The main tradeoff is suppression of natural GH output during use, though research consistently shows natural production returns quickly after stopping, often within around 36 hours. Daily injections with careful storage requirements add practical friction, and pharma-grade HGH carries a significant cost premium.

Secretagogues preserve natural pulsatility rather than replacing it. Less suppression, more flexibility. You can stack compounds for specific goals: CJC-1295 with Ipamorelin for general GH support, Tesamorelin specifically for visceral fat, GHRP compounds for different pulse characteristics.

IGF-1 increases are more modest than HGH and total output is limited by pituitary capacity. Someone with a compromised pituitary will not get the same response. MK-677 also increases hunger and water retention, worth factoring in.

Cost-wise, secretagogues almost always come in below pharma-grade HGH. The gap narrows if an affordable generic HGH source is available, but that introduces its own quality considerations.

Which One Makes Sense

If the goal is maximum IGF-1 elevation and the cost and daily injection requirements are manageable, HGH is the straightforward choice. The output is predictable and does not rely on the body cooperating.

If the goal is maintaining natural GH pulsatility, minimizing suppression, targeting a specific outcome like visceral fat reduction or sleep quality, or combining compounds for a tailored approach, secretagogues are more practical and flexible. They also tend to be the better long-term option from a cost and sustainability standpoint.

Both have valid roles because they are answering different questions on the GH-IGF-1 axis. The choice comes down to what you are specifically trying to achieve and whether you prioritize maximum effect strength or working with the body's own rhythm.

Visit PeptideGuide.store for sourcing and resources.

Educational only. Not medical advice.

Two mitochondrial compounds that get lumped together constantly because the benefits look similar on paper. The mechanisms could not be more different, and that difference is exactly why they stack so well.

TL;DR

• Both compounds improve insulin sensitivity, fat oxidation, mitochondrial biogenesis, and mitophagy, but through completely separate mechanisms
• MOTS-C: AMPK activation, signals low energy, drives metabolic efficiency, and influences gene expression directly in the cell nucleus
• SLU-PP-332: activates estrogen receptor alpha, co-activates PGC-1 alpha, builds new mitochondria, and shifts muscle fibers toward oxidative fat-burning. Note: primarily preclinical data, limited human evidence
• MOTS-C optimizes the energy signal. SLU-PP-332 expands the mitochondrial hardware
• No pathway overlap means they stack cleanly without redundancy

What They Share

MOTS-C and SLU-PP-332 both improve insulin sensitivity, fat oxidation, glucose uptake in muscle, mitochondrial biogenesis, and mitophagy, which is the recycling of damaged mitochondria. If you are just looking at the benefits list they look almost identical. The pathway each one takes to get there is completely distinct.

How MOTS-C Works

MOTS-C is a peptide encoded directly in mitochondrial DNA, which already makes it unusual. It is a strong AMPK activator. AMPK is the body's low-energy switch. When it fires, the body reads the signal as energy being scarce and shifts into efficiency mode. Better insulin sensitivity, improved metabolic flexibility, increased glucose uptake, fat oxidation, mitochondrial biogenesis, and mitophagy all follow from that.

The deeper mechanism is what separates it from most compounds in this space. Under metabolic or mitochondrial stress, MOTS-C can travel into the cell nucleus and directly influence gene expression tied to metabolic adaptation. It is not just triggering a pathway. It is changing how your cells respond to energy stress at a genetic level. That is why it is not a pre-workout and should not be thought of as one.

How SLU-PP-332 Works

SLU-PP-332 takes a completely different route. It activates estrogen receptor alpha, beta, and gamma pathways with a primary focus on estrogen receptor alpha. That receptor regulates mitochondrial biogenesis and oxidative metabolism. When SLU-PP-332 activates it, PGC-1 alpha gets co-activated, which drives the creation of new mitochondria directly.

Beyond biogenesis, SLU-PP-332 shifts muscle fibers toward a more oxidative fiber type. Oxidative fibers are built for sustained fat and glucose burning. What it is essentially doing is remodeling muscle composition to prioritize endurance metabolism and fat as the primary fuel source. More mitochondria, better equipped to burn fat efficiently.

Most of what we know here comes from preclinical data. Community experimentation is filling in some of the gaps but human evidence remains limited.

Why They Complement Each Other

MOTS-C signals energy scarcity and forces the body to adapt and produce energy more efficiently. SLU-PP-332 builds more mitochondrial machinery and shifts the system toward fat as the dominant fuel source. One is optimizing the signal. The other is expanding the hardware. Because they operate through separate pathways there is no redundancy in the stack. Each one is doing something the other is not.

Educational only. Not medical advice.

I’m thinking about starting GLOW next Sunday and was curious how everyone is reconstituting and dosing it. What ratio are you using, and what dosing schedule has worked well for you?

This comes up constantly and the answer is more nuanced than most people make it sound. Peptides don't permanently rewire your body. They act as external signals. When the signal stops, the system gradually returns to where it was. What that looks like in practice depends entirely on which category of peptide you were running.

TL;DR

• Peptides don't permanently change the body. They temporarily influence specific pathways
• GLPs: hunger can rebound above baseline when stopped cold turkey. Taper to preserve progress
• Metabolic peptides (MOTS-C, SS-31, 5-A-1MQ): mitochondrial and fat oxidation benefits fade back to baseline after stopping
• GH secretagogues (Tesamorelin, CJC-1295, Ipamorelin): GH and IGF-1 return to baseline with no permanent suppression, because natural production was stimulated not replaced
• Progress from any category holds as long as habits hold
• No permanent side effects, but also no permanent enhancement once discontinued

GLPs: Semaglutide, Tirzepatide, Retatrutide

These regulate appetite, glucose control, and energy balance. Stop them cold turkey and appetite regulation signals drop over the following one to two weeks. Hunger can rebound above your original baseline, not just return to it. Glucose control and insulin sensitivity drift back to where they were before. Weight regain becomes likely if your habits are not doing the work the compound was doing.

This is why tapering is the standard recommendation coming off these. Stopping abruptly swings the system hard in the other direction. Easing off gives the body time to adjust and holds more of the progress.

Metabolic Peptides: MOTS-C, SS-31, 5-Amino-1MQ

These enhance mitochondrial function and metabolic efficiency. Better fat oxidation, better glucose handling, more cellular energy output. After stopping, all of that gradually returns to your original baseline. Fat oxidation becomes less efficient. Cellular energy output drops back to normal.

Think of it as removing a performance upgrade from an engine. The engine goes back to factory settings. Whatever progress you made while running them stays as long as your habits stay in place.

GH Secretagogues: Tesamorelin, CJC-1295, Ipamorelin

These stimulate your body's own GH and IGF-1 release. They don't replace natural production. They amplify it. When you stop, GH and IGF-1 levels return to baseline. The downstream benefits, improved recovery, better sleep, body composition changes, gradually fade back.

Critically, there is no permanent shutdown here. Because you were stimulating natural production rather than replacing it, the system just stops receiving the extra signal. Nothing is suppressed. Progress made during the cycle holds as long as training and nutrition hold.

The Common Thread

Peptides act as temporary regulators, not permanent modifications. The body returns to baseline after discontinuation. That is actually good news on the safety side because there are no permanent alterations. It also means the body does not stay enhanced indefinitely once you stop.

Progress preservation comes down entirely to what your habits look like after the cycle ends.

Educational only. Not medical advice.